{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:29:26Z","timestamp":1790260166020,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.canlet.2015.11.036","type":"journal-article","created":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T12:52:12Z","timestamp":1449233532000},"page":"161-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells"],"prefix":"10.1016","volume":"371","author":[{"given":"Gustavo J.","family":"Melen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Franco-Luz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ruano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1frica","family":"Gonz\u00e1lez-Murillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantzazu","family":"Alfranca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Casco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Lassaletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Madero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Alemany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garc\u00eda-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2015.11.036_bib0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc3770","article-title":"Going viral with cancer immunotherapy","volume":"14","author":"Lichty","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2015.11.036_bib0015","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/pbc.25366","article-title":"Attack of the cancer-killing viruses: clinical application of oncolytic virotherapy in children","volume":"62","author":"Friedman","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.canlet.2015.11.036_bib0020","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2174\/156652321306140103224907","article-title":"Biosafety of non-human therapeutic viruses in clinical gene therapy","volume":"13","author":"Hoeben","year":"2013","journal-title":"Curr. Gene Ther"},{"key":"10.1016\/j.canlet.2015.11.036_bib0025","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2217\/imt.13.123","article-title":"Evolution of oncolytic viruses: novel strategies for cancer treatment","volume":"5","author":"Atherton","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.canlet.2015.11.036_bib0030","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1158\/0008-5472.CAN-14-0876","article-title":"Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus","volume":"74","author":"Zemp","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.11.036_bib0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/gt.2012.31","article-title":"Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses","volume":"20","author":"Peng","year":"2013","journal-title":"Gene Ther"},{"key":"10.1016\/j.canlet.2015.11.036_bib0040","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/cgt.2010.4","article-title":"Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study","volume":"17","author":"Garc\u00eda-Castro","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.canlet.2015.11.036_bib0045","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/sj.mt.6300239","article-title":"Systemic toxicity-efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway","volume":"15","author":"Cascallo","year":"2007","journal-title":"Mol. Ther"},{"key":"10.1016\/j.canlet.2015.11.036_bib0050","doi-asserted-by":"crossref","first-page":"8255","DOI":"10.1158\/0008-5472.CAN-06-4675","article-title":"ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo","volume":"67","author":"Alonso","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.11.036_bib0055","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/bmt.2012.43","article-title":"Early evaluation of immune reconstitution following allogeneic CD3\/CD19-depleted grafts from alternative donors in childhood acute leukemia","volume":"47","author":"P\u00e9rez-Mart\u00ednez","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.canlet.2015.11.036_bib0060","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.canlet.2015.11.036_bib0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ncponc0736","article-title":"Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress","volume":"4","author":"Liu","year":"2007","journal-title":"Nat. Clin. Pract. Oncol"},{"key":"10.1016\/j.canlet.2015.11.036_bib0070","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbrc.2011.03.093","article-title":"CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas","volume":"407","author":"Kim","year":"2011","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.canlet.2015.11.036_bib0075","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3109\/14653240903233099","article-title":"Overexpression of CXCR1\/CXCR2 on mesenchymal stromal cells may be an effective treatment for acute myocardial infarction","volume":"11","author":"Xu","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.canlet.2015.11.036_bib0080","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1161\/CIRCRESAHA.109.196030","article-title":"Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium","volume":"106","author":"Huang","year":"2010","journal-title":"Circ. Res"},{"key":"10.1016\/j.canlet.2015.11.036_bib0085","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1084\/jem.20011284","article-title":"Hematopoietic stem cells are uniquely selective in their migratory response to chemokines","volume":"195","author":"Wright","year":"2002","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.canlet.2015.11.036_bib0090","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood-2004-02-0526","article-title":"A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow","volume":"104","author":"Wynn","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2015.11.036_bib0095","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.4049\/jimmunol.1402097","article-title":"Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors","volume":"194","author":"Lourenco","year":"2015","journal-title":"J. Immunol"},{"key":"10.1016\/j.canlet.2015.11.036_bib0100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1593\/neo.06841","article-title":"Ets1 transcription factor mediates gastrin-releasing peptide-induced IL-8 regulation in neuroblastoma cells","volume":"9","author":"Qiao","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2015.11.036_bib0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.semcancer.2008.11.002","article-title":"Chemokines and the microenvironment in neuroectodermal tumor-host interaction","volume":"19","author":"Somasundaram","year":"2009","journal-title":"Semin. Cancer Biol"},{"key":"10.1016\/j.canlet.2015.11.036_bib0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.semcancer.2008.10.009","article-title":"Chemokines in neuroectodermal cancers: the crucial growth signal from the soil","volume":"19","author":"Gross","year":"2009","journal-title":"Semin. Cancer Biol"},{"key":"10.1016\/j.canlet.2015.11.036_bib0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/09553002.2012.666001","article-title":"Gamma radiation induces senescence in human adult mesenchymal stem cells from bone marrow and periodontal ligaments","volume":"88","author":"Cmielova","year":"2012","journal-title":"Int. J. Radiat. Biol"},{"key":"10.1016\/j.canlet.2015.11.036_bib0120","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.4161\/cc.10.21.17972","article-title":"Activation of DNA damage response pathways in human mesenchymal stem cells exposed to cisplatin or \u03b3-irradiation","volume":"10","author":"Prendergast","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2015.11.036_bib0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/ten.tec.2013.0766","article-title":"Effect of high-dose irradiation on human bone-marrow-derived mesenchymal stromal cells","volume":"21","author":"Fekete","year":"2015","journal-title":"Tissue Eng. Part C Methods"},{"key":"10.1016\/j.canlet.2015.11.036_bib0130","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/mt.2011.65","article-title":"Thunder and lightning: immunotherapy and oncolytic viruses collide","volume":"19","author":"Melcher","year":"2011","journal-title":"Mol. Ther"},{"key":"10.1016\/j.canlet.2015.11.036_bib0135","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2015.11.036_bib0140","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu. Rev. Immunol"},{"key":"10.1016\/j.canlet.2015.11.036_bib0145","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nm.3089","article-title":"Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer","volume":"19","author":"Heo","year":"2013","journal-title":"Nat. Med"},{"key":"10.1016\/j.canlet.2015.11.036_bib0150","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2217\/fon.10.66","article-title":"OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma","volume":"6","author":"Kaufman","year":"2010","journal-title":"Future Oncol"},{"key":"10.1016\/j.canlet.2015.11.036_bib0155","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008095","article-title":"Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy","volume":"6","author":"Zamarin","year":"2014","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.canlet.2015.11.036_bib0160","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1158\/2326-6066.CIR-14-0220-T","article-title":"Adenovirus improves the efficacy of adoptive T-cell therapy by recruiting immune cells to and promoting their activity at the tumor","volume":"3","author":"T\u00e4htinen","year":"2015","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.canlet.2015.11.036_bib0165","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.190.Supp.214.11","article-title":"Therapeutic effect of mesenchymal stem cells in combination with oncolytic adenoviruses for the treatment of solid tumors in an immunocompetent mouse model (P2020)","volume":"190","author":"Rincon","year":"2013","journal-title":"J. Immunol"},{"key":"10.1016\/j.canlet.2015.11.036_bib0170","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","article-title":"Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness","volume":"105","author":"Beyth","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2015.11.036_bib0175","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","article-title":"Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells","volume":"105","author":"Jiang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2015.11.036_bib0180","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4049\/jimmunol.180.3.1598","article-title":"Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway","volume":"180","author":"Li","year":"2008","journal-title":"J. Immunol"},{"key":"10.1016\/j.canlet.2015.11.036_bib0185","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood-2008-04-154138","article-title":"Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2015.11.036_bib0190","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2015.11.036_bib0195","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/scrt75","article-title":"Mesenchymal stem cell effects on T-cell effector pathways","volume":"2","author":"Duffy","year":"2011","journal-title":"Stem Cell Res. Ther"},{"key":"10.1016\/j.canlet.2015.11.036_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04327.x","article-title":"Immunomodulatory properties and therapeutic application of mesenchymal stem cells","volume":"164","author":"Shi","year":"2011","journal-title":"Clin. Exp. Immunol"},{"key":"10.1016\/j.canlet.2015.11.036_bib0205","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3324\/haematol.12857","article-title":"The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes","volume":"93","author":"Tabera","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2015.11.036_bib0210","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2015.11.036_bib0215","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/jcmm.12264","article-title":"Gamma irradiation preserves immunosuppressive potential and inhibits clonogenic capacity of human bone marrow-derived mesenchymal stromal cells","volume":"18","author":"de Andrade","year":"2014","journal-title":"J. Cell. Mol. Med"},{"key":"10.1016\/j.canlet.2015.11.036_bib0220","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.immuni.2006.09.005","article-title":"Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses","volume":"25","author":"Yewdell","year":"2006","journal-title":"Immunity"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515007260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515007260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T01:58:19Z","timestamp":1692151099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383515007260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0304383515007260"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2015.11.036","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2015.11.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}